Citations (39)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Daniel Smith, Christian Cable, Cary Chisholm, Walter Linz, William Koss, Sheila Dobin & Edward Rappaport. (2011) Mantle cell leukemia as a cause of leukostasis. Blood and Lymphatic Cancer: Targets and Therapy 1, pages 5-8.
Read now
Read now
E Matutes, N Parry-Jones, V Brito-Babapulle, A Wotherspoon, R Morilla, S Atkinson, MO Elnenaei, P Jain, GM Giustolisi, RP A'hern & D Catovsky. (2004) The Leukemic Presentation of Mantle-cell Lymphoma: Disease Features and Prognostic Factors in 58 Patients. Leukemia & Lymphoma 45:10, pages 2007-2015.
Read now
Read now
A. H. Strickland, K. A. Marsden, J. McArdle & R. M. Lowenthal. (2001) Pathologic Splenic Rupture as the Presentation of Mantle Cell Lymphoma. Leukemia & Lymphoma 41:1-2, pages 197-201.
Read now
Read now
Francesco Bertoni, Enrico Roggero, Peter Luscieti, Ennio Pedrinis, Franco Cavalli & Emanuele Zucca. (1999) Clonality Assessment in Blood of Patients with Mantle Cell Lymphoma. Leukemia & Lymphoma 32:3-4, pages 375-379.
Read now
Read now
Articles from other publishers (35)
Melissa Lumish, Lorenzo Falchi, Brandon S. Imber, Michael Scordo, Gottfried von Keudell & Erel Joffe. (2021) How we treat mature B-cell neoplasms (indolent B-cell lymphomas). Journal of Hematology & Oncology 14:1.
Crossref
Crossref
Olga V. Danilova. 2020. Follicular Lymphoma and Mantle Cell Lymphoma. Follicular Lymphoma and Mantle Cell Lymphoma
49
93
.
Shahram Mori, Rushang D. Patel, Sarfraz Ahmad, Juan Varela, Tori Smith, Rola Altoos, Qi Shen, Steven C. Goldstein & Daniel O. Persky. (2019) Aggressive Leukemic Non-Nodal Mantle Cell Lymphoma With P53 Gene Rearrangement/Mutation is Highly Responsive to Rituximab/Ibrutinib Combination Therapy. Clinical Lymphoma Myeloma and Leukemia 19:2, pages e93-e97.
Crossref
Crossref
Mathieu Gallo, Valère Cacheux, Laure Vincent, Caroline Bret, Ariane Tempier, Caroline Guittard, Alexandra Macé, Nicolas Leventoux, Valérie Costes & Vanessa Szablewski. (2016) Leukemic non-nodal mantle cell lymphomas have a distinct phenotype and are associated with deletion of PARP1 and 13q14. Virchows Archiv 469:6, pages 697-706.
Crossref
Crossref
Gary Lam, Rena Xian, Yingying Li, Kathleen Burns & Karen Beemon. (2016) Lack of TERT Promoter Mutations in Human B-Cell Non-Hodgkin Lymphoma. Genes 7:11, pages 93.
Crossref
Crossref
Julieta Panero, Raquel M. Alves‐Paiva, Alejandro Roisman, Barbara A. Santana‐Lemos, Roberto P. Falcão, Gustavo Oliveira, Diego Martins, Carmen Stanganelli, Irma Slavutsky & Rodrigo T. Calado. (2016)
Acquired
TERT
promoter mutations stimulate
TERT
transcription in mantle cell lymphoma
. American Journal of Hematology 91:5, pages 481-485.
Crossref
Crossref
Etienne Mahe, Ariz Akhter, Anne Le, Lelsey Street, Payam Pournaziri, Farid Kosari, Meer-Taher Shabani-Rad, Douglas Stewart & Adnan Mansoor. (2015) PARP1 expression in mantle cell lymphoma: the utility of PARP1 immunohistochemistry and its relationship with markers of DNA damage. Hematological Oncology 33:4, pages 159-165.
Crossref
Crossref
Pavla Vesel?Zbyn?k Tonar, David ??lek, Samuel Vokurka, Marek Trn?n?Roman Kodet, Mojm?r Moulis, Petra Ka?parov?Zde?ka Vernerov?Zuzana Velensk?Jan St??tesk?Michal Michal & Ludmila Boudov?. (2014) Microvessel density of mantle cell lymphoma. A retrospective study of its prognostic role and the correlation with the Ki-67 and the mantle cell lymphoma international prognostic index in 177 cases. Virchows Archiv 465:5, pages 587-597.
Crossref
Crossref
Blanca Espinet, Ana Ferrer, Beatriz Bellosillo, Lara Nonell, Antonio Salar, Concepción Fernández-Rodríguez, Eulàlia Puigdecanet, Javier Gimeno, Mar Garcia-Garcia, Maria Carmen Vela, Elisa Luño, Rosa Collado, José Tomás Navarro, Esmeralda de la Banda, Pau Abrisqueta, Leonor Arenillas, Cristina Serrano, Josep Lloreta, Belén Miñana, Andrea Cerutti, Lourdes Florensa, Alberto Orfao, Ferran Sanz, Francesc Solé, David Dominguez-Sola & Sergio Serrano. (2014) Distinction between Asymptomatic Monoclonal B-cell Lymphocytosis with Cyclin D1 Overexpression and Mantle Cell Lymphoma: From Molecular Profiling to Flow Cytometry. Clinical Cancer Research 20:4, pages 1007-1019.
Crossref
Crossref
Wei Liu, L. Jeffrey Medeiros, Pei Lin, Jorge E. Romaguera, Sa A. Wang & Jeffrey L. Jorgensen. (2012) Usefulness of Flow Cytometric Immunophenotyping for Bone Marrow Staging in Patients With Mantle Cell Lymphoma After Therapy. American Journal of Clinical Pathology 137:4, pages 634-640.
Crossref
Crossref
Sergio Cortelazzo, Maurilio Ponzoni, Andrés J.M. Ferreri & Martin Dreyling. (2012) Mantle cell lymphoma. Critical Reviews in Oncology/Hematology 82:1, pages 78-101.
Crossref
Crossref
Paul J. Kurtin. 2012. Hematopathology. Hematopathology
205
260
.
Elias Campo, Pedro Jares & Elaine S. Jaffe. 2011. Hematopathology. Hematopathology
333
348
.
Richard D. Brunning & Daniel A. Arber. 2011. Rosai and Ackerman's Surgical Pathology. Rosai and Ackerman's Surgical Pathology
1927
2012
.
Paul J. Kurtin. (2009) Indolent Lymphomas of Mature B Lymphocytes. Hematology/Oncology Clinics of North America 23:4, pages 769-790.
Crossref
Crossref
Pedro Jares & Elas Campo. (2008) Advances in the understanding of mantle cell lymphoma. British Journal of Haematology 142:2, pages 149-165.
Crossref
Crossref
M. Todorovic, M. Pavlovic, B. Balint, N. Kraguljac, B. Mihaljevic, A. Bogdanovic, I. Elezovic, D. Boskovic & M. Colovic. (2007) Immunophenotypic profile and clinical characteristics in patients with advanced stage mantle cell lymphoma. Medical Oncology 24:4, pages 413-418.
Crossref
Crossref
Ana Ferrer, Itziar Salaverria, Francesc Bosch, Neus Villamor, María Rozman, Silvia Beà, Eva Giné, Armando López‐Guillermo, Elías Campo & Emili Montserrat. (2007) Leukemic involvement is a common feature in mantle cell lymphoma. Cancer 109:12, pages 2473-2480.
Crossref
Crossref
Marcus Kremer, Leticia Quintanilla-Martínez, Jörg Nährig, Christoph von Schilling & Falko Fend. (2005) Immunohistochemistry in bone marrow pathology: a useful adjunct for morphologic diagnosis. Virchows Archiv 447:6, pages 920-937.
Crossref
Crossref
Marc D Smith, Timothy P Singleton, Savitha Balaraman, Ishmael Jaiyesimi, Barbara O'Malley, Abdul Al-Saadi & Joan C Mattson. (2004) Case report: mantle cell lymphoma, prolymphocytoid variant, with leukostasis syndrome. Modern Pathology 17:7, pages 879-883.
Crossref
Crossref
Jun Gu, Yang O Huh, Feng Jiang, Nancy P Caraway, Jorge E Romaguera, Tanweer M Zaidi, Ricardo L Fernandez, Huazhong Zhang, Issa F Khouri & Ruth L Katz. (2004) Evaluation of peripheral blood involvement of mantle cell lymphoma by fluorescence in situ hybridization in comparison with immunophenotypic and morphologic findings. Modern Pathology 17:5, pages 553-560.
Crossref
Crossref
Alfred Christian Feller & Jacques DieboldAlfred Christian Feller & Jacques Diebold. 2004. Histopathology of Nodal and Extranodal Non-Hodgkin’s Lymphomas. Histopathology of Nodal and Extranodal Non-Hodgkin’s Lymphomas
396
408
.
Alfred Christian Feller & Jacques DieboldAlfred Christian Feller & Jacques Diebold. 2004. Histopathology of Nodal and Extranodal Non-Hodgkin’s Lymphomas. Histopathology of Nodal and Extranodal Non-Hodgkin’s Lymphomas
19
120
.
Ellen Schlette, Kai Fu & L. Jeffrey Medeiros. (2003) CD23 Expression in Mantle Cell Lymphoma: Clinicopathologic Features of 18 Cases. American Journal of Clinical Pathology 120:5, pages 760-766.
Crossref
Crossref
Rosa Ruchlemer, Andrew C. Wotherspoon, Jeremy N. Thompson, John G. Swansbury, Estella Matutes & Daniel Catovsky. (2002) Splenectomy in mantle cell lymphoma with leukaemia: a comparison with chronic lymphocytic leukaemia. British Journal of Haematology 118:4, pages 952-958.
Crossref
Crossref
Joel A. Chan, Xiangdong Bu, Keith K. Lai & Bharat N. Nathwani. (2002) Mantle Cell Lymphoma, ?Blastoid? Variant (WHO Classification), Producing Distinctive Morphologic Patterns. Pathology Case Reviews 7:3, pages 88-96.
Crossref
Crossref
Orion M. HowardJohn G. GribbenDonna S. NeubergMichael GrossbardChristina PoorMilos J. JanicekMargaret A. Shipp. (2002) Rituximab and CHOP Induction Therapy for Newly Diagnosed Mantle-Cell Lymphoma: Molecular Complete Responses Are Not Predictive of Progression-Free Survival. Journal of Clinical Oncology 20:5, pages 1288-1294.
Crossref
Crossref
Mihaela Onciu, Ellen Schlette, L. Jeffrey Medeiros, Lynne V. Abruzzo, Michael Keating & Raymond Lai. (2001) Cytogenetic Findings in Mantle Cell Lymphoma. American Journal of Clinical Pathology 116:6, pages 886-892.
Crossref
Crossref
Ellen Schlette, Raymond Lai, Mihaela Onciu, Dorota Doherty, Carlos Bueso-Ramos & L Jeffrey Medeiros. (2001) Leukemic Mantle Cell Lymphoma: Clinical and Pathologic Spectrum of Twenty-Three Cases. Modern Pathology 14:11, pages 1133-1140.
Crossref
Crossref
Raymond Lai & L. Jeffrey Medeiros. (2000) Pathologic Diagnosis of Mantle Cell Lymphoma. Clinical Lymphoma 1:3, pages 197-206.
Crossref
Crossref
David S Viswanatha, Kathryn Foucar, Brian R Berry, Randy D Gascoyne, H Lance Evans & Catherine P Leith. (2000) Blastic Mantle Cell Leukemia: An Unusual Presentation of Blastic Mantle Cell Lymphoma. Modern Pathology 13:7, pages 825-833.
Crossref
Crossref
Kit-Fai Wong, John K. C. Chan, Jason C. C. So & Pui-Hung Yu. (1999) Mantle cell lymphoma in leukemic phase. Cancer 86:5, pages 850-857.
Crossref
Crossref
Pierluigi Porcu & Craig R. Nichols. (1998) Evaluation and management of the “New” lymphoma entities: Mantle cell lymphoma, lymphoma of mucosa-associated lymphoid tissue, anaplastic large-cell lymphoma, and primary mediastinal B-cell lymphoma. Current Problems in Cancer 22:5, pages 283-368.
Crossref
Crossref
Cohen Kurtin Donovan Hanson. (2001) Bone marrow and peripheral blood involvement in mantle cell lymphoma. British Journal of Haematology 101:2, pages 302-310.
Crossref
Crossref
Larry H. ArgatoffJoseph M. ConnorsRichard J. KlasaDouglas E. HorsmanRandy D. Gascoyne. (1997) Mantle Cell Lymphoma: A Clinicopathologic Study of 80 Cases. Blood 89:6, pages 2067-2078.
Crossref
Crossref